REFERENCES
- Sabanayagam C, Lim SC, Wong TY, . Ethnic disparities in prevalence and impact of risk factors of chronic kidney disease. Nephrol Dial Transplant. 2010;25(8):2564–2570.
- Kang DH, Kanellis J, Hugo C, . Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol. 2002;13(3):806–816.
- Jain P, Shah S, Razek C, . Potentials and limitations of microorganisms as renal failure biotherapeutics. Biologics Targets Ther. 2009;3:233–243.
- Zheng H, Yunsheng J, Ji-an L. Influence factors in the clearance of urea and creatinine through gastrointestinal tract. Bull Hunan Med Univ. 1999;24(6):513–532.
- Wang Y, Wang DH. Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA‐salt hypertension. Am J Physiol Renal Physiol. 2009;297(6):F1550–F1559.
- Chow KM, Liu ZC, Chang TM, . Animal remnant kidney model of chronic renal revisited. Hong Kong J Nephrol. 2003;5(2):57–64.
- Švíglerová J, Kuncová J, Nalos L, . Cardiovascular parameters in rat model of chronic renal failure induced by subtotal nephrectomy. Physiol Res. 2010;59(Suppl. 1): S81–S88.
- Calunga JL, Zamora ZB, Borrego A, . Ozone therapy on rats submitted to subtotal nephrectomy: Role of antioxidant system. Mediators of inflammation. Mediators Inflamm. 2005;2005(4):221–227.
- Sasaki S, Yokozawa T, Cho EJ, . Protective role of gamma-aminobutyric acid against chronic renal failure in rats. J Pharm Pharmacol. 2006;58(11):1515–1525.
- Yoshioka T, Shiraga H, Yoshiyuki Y, . “Intact nephrons” as the primary origin of proteinuria in chronic renal disease. J Clin Invest. 1988;82(5):1614–1623.
- Fauci AS, Braunwald E, Isselbacher KJ, . Chronic renal failure. In: Braunwald E, Hauser SL, Fauci AS, Longo DL, Kasper DL, Jameson JL, eds. Harrison’s Principles of Internal Medicine. New York: McGraw-Hill; 1998:1513–1520.
- Lane PH. Long-term furosemide treatment in the normal rat: Dissociation of glomerular hypertrophy and glomerulosclerosis. Am J Kidney Dis. 1999;33(6):1058–1063.
- Slomowitz L. Tubuloglomerular feedback in chronic renal failure. Nephron. 1987;45(4):264–271.
- Sheldin DW, Gusbech G. The kidney physiology and physiopathology. In: Roven P, ed. The Kidney Physiology and Physiopathology. New York: Roven Press; 1985:1901–1905.
- Kang DH, Anderson S, Kim YG, . Impaired angiogenesis in the aging kidney: Vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis. 2001;37(3):601–611.
- Kang DH, Joly AH, Oh SW, . Impaired angiogenesis in the remnant kidney model (I): Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol. 2001;12(7):1434–1447.
- Thomas SE, Anderson S, Gordon KL, . Tubulointerstitial disease in aging: Evidence for peritubular capillary damage, a potential role for renal ischemia. J Am Soc Nephrol. 1998;9(2): 231–242.
- Ohashi R, Kitamura H, Yamanaka N. Peritubular capillary injury during the progression of experimental glomerulonephritis in rats. J Am Soc Nephrol. 2000;11(1):47–56.
- Gerber HP, Hillan K, Ryan A, . VEGF is required for growth and survival in neonatal mice. Development. 1999;126: 1149–1159.
- Brown LF, Berse B, Tognazzi K, . Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int. 1992;42:1457–1461.
- Kretzler M, Schroppel B, Merkle M, . Detection of multiple vascular endothelial growth factor splice isoforms in single glomerular podocytes. Kidney Int Suppl. 1998;67:S159–S161.
- Shulman K, Rosen S, Tognazzi K, . Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases. J Am Soc Nephrol. 1996;7:661–666.
- Grone J-J, Simon M, Grone EF. Expression of vascular endothelial growth factor in renal vascular disease and renal allografts. J Pathol. 1995;177:259–267.
- Kang D-H, Joly AH, Oh S-W, . Impaired angiogenesis in the remnant kidney model. I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol. 2001;12:1434–1447.